Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To determine the efficacy and durability (treatment interval) of 2 mg IVT aflibercept in a T&E regimen over a treatment period of 76 weeks using protocol defined visual and anatomic criteria in subjects with macular edema secondary to CRVO
Inclusion criteria
- Macular edema secondary to CRVO